Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Fortune Indonesia Tbk (FORU) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Fortune Indonesia TbkTrade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Fortune Indonesia Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Fortune Indonesia Tbk trades at Rp2,950 (market cap 1.36T, 604.9K 24h volume). The key difference: Fortune Indonesia Tbk is far larger — about 4.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 604.9K). Which is the better fit depends on your goals.

DGNSFORU
Market Cap
310.75B1.36T
Volume
963.6K604.9K
Lot
9.64K6.05K
Turnover
217.67M1.77B
Average Price
225.892,925.97
Value
217.67M1.77B
Indicative Equilibrium Price
2262,950
Indicative Equilibrium Volume
1K22

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
FORU
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Fortune Indonesia Tbk

PT. Fortune Indonesia, Tbk (the Company) was established under its original name of PT Fortune Indonesia Advertising Company based on Notarial Deed No. 5 of Dian Paramita Tamzil, S.H., dated May 5, 1970.

Read more on FORU